Positivity of Stool Pathogen Sampling in Pediatric Inflammatory Bowel Disease Flares and Its Association With Disease

Pesah Melnik1, Niv Soffair1, Manar Matar1

  • 1Institute of Gastroenterology, Nutrition and Liver Disease, Schneider Children's Medical Center, Petach Tikva.

Insights

Clostridium difficile infections, not Campylobacter jejuni, are linked to more severe outcomes in pediatric inflammatory bowel disease (IBD) flares. This finding highlights the importance of identifying specific enteric pathogens during IBD exacerbations.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Inflammatory Bowel Disease (IBD) Research

Background:

  • Acute exacerbations of inflammatory bowel disease (IBD) in children can be complicated by enteric infections.
  • Identifying specific pathogens during IBD flares is crucial for understanding disease severity and outcomes.

Purpose of the Study:

  • To determine the frequency of Clostridium difficile toxin (CDT) and non-CDT enteric infections in pediatric IBD patients experiencing symptomatic flares.
  • To compare the 1-year outcomes of pediatric IBD patients with CDT or other enteric infections versus those without.

Main Methods:

  • Retrospective analysis of medical records for pediatric IBD patients with documented disease flares and stool sample collection.
  • Matching of patients with positive enteric pathogen results to IBD patients with negative results for comparative outcome analysis.
  • Evaluation of 1-year outcomes including disease flares, emergency room visits, and surgical interventions.

Main Results:

  • Campylobacter jejuni and Clostridium difficile were the most common enteric infections identified.
  • Pediatric IBD patients with positive Clostridium difficile toxin (CDT) results experienced significantly more disease flares and emergency room visits within 12 months compared to controls.
  • A trend towards increased surgical interventions was observed in patients with CDT infections, though not statistically significant.

Conclusions:

  • Clostridium difficile infection is associated with a more severe disease course in pediatric patients with inflammatory bowel disease flares.
  • Campylobacter jejuni infections did not show a significant association with worse disease outcomes in this cohort.
  • Targeted identification and management of Clostridium difficile are important during IBD exacerbations in children.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
537
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
614
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
770
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
715
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
616
Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture01:26

Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture

Sputum studies are a critical part of diagnosing and treating numerous respiratory conditions. These studies involve obtaining sputum samples for analysis to identify pathogenic organisms and assess the presence of abnormal cells indicative of malignant conditions. This lesson will delve into three fundamental sputum studies: Gram Stain, Cytology, and Acid-fast Smear and Culture.
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
455